Bright Minds Biosciences Inc banner

Intrinsic Value

Is DRUG undervalued or overvalued?

See the intrinsic value estimate for Bright Minds Biosciences Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

DRUG Intrinsic Value
LOCKED
Unlock
Today vs. history

DRUG looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with DRUG’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor DRUG
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price CA$74.67
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to DRUG

Fundamental Analysis

What Bright Minds Biosciences Does

Biotechnology Health Care

Bright Minds Biosciences is a drug development company that creates new medicines based on serotonin biology, with a focus on brain and nervous system disorders. It does not sell consumer products. Instead, it builds a pipeline of drug candidates designed to treat conditions such as epilepsy, depression, and pain, especially where current therapies do not work well enough.

Headquarters
United States of America US
IPO date
Feb 8, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Bright Minds Biosciences Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one DRUG stock?

The intrinsic value for Bright Minds Biosciences Inc (DRUG) under the Base Case is hidden CAD.

Is DRUG stock undervalued or overvalued?

Compared with the current market price of 74.67 CAD, the stock appears hidden.

Back to Top